Anti-Notch plus endocrine therapy in ER<sup>+</sup> breast cancer inhibits cancer stem cells by increasing DAXX

Kathy S. Albain; Debra Wyatt; Andrei Zlobin; Susan G. Hilsenbeck; Cheryl M. Czerlanis; Daniel S. Peiffer; Kyle R. Convington; Constantine Godellas; Shelly S. Lo; Patricia A. Robinson; Kathy Czaplicki; Barbara Busby; Davide Bova; Ping Tang; Patrick J. Stiff; Suzanne A.W. Fuqua; Lucio Miele; Clodia Osipo

doi:10.1172/jci.insight.172506

¹Department of Medicine, Division of Hematology/Oncology, Loyola University Chicago Stritch School of Medicine, Cardinal Bernardin Cancer Center, Maywood, United States of America

²Department of Cancer Biology, Loyola University Chicago, Maywood, United States of America

³Baylor College of Medicine, Houston, United States of America

⁴University of Wisconsin Health, Madison, United States of America

⁵Department of Medicine, University of Chicago, Chicago, United States of America

⁶Department of Surgery, Division of Surgical Oncology, Ascension Medical Group Illinois, Elk Grove Village, United States of America

⁷RUSH MD Anderson Cancer Center, Rush University Medical Center, Chicago, United States of America

⁸Department of Medicine (Hematology and Oncology), Northwestern University, Chicago, United States of America

⁹Department of Radiology, Loyola University Chicago Stritch School of Medicine, Maywood, United States of America

¹⁰Division of Surgical Pathology, Cook County Health, Chicago, United States of America

¹¹Department of Microbiology, Genetics and Immunology, Louisiana State University Health Sciences Center and LSU-LCMC Health Cancer Center, New Orleans, United States of America

Find articles by Albain, K. in: PubMed | Google Scholar